PMID 34180047
The first to be approved for this indication was liraglutide (Saxenda) in 2014, followed by semaglutide (Wegovy) in 2021 and tirzepatide (Zepbound
PierpaoliECirioniOSimonettiOOrlandoFGiacomettiALombardiPet al
Wilson WA, Hughes WE, Tomamichel W, Roach PJ
Ingredients: Water, Centella Asiatica Extract, Butylene Glycol, Dipropylene Glycol, Nelumbo Nucifera Germ Extract, Artemisia Annua Extract, Oryza Sativa Extract, Saccharomyces Ferment, Niacinamide, Glutathione, Solanum Melongena Fruit Extract, Melaleuca Alternifolia Leaf Extract, Hydrolyzed Collagen, Beta-Glucan, Hippophae Rhamnoides Fruit Extract, Sodium Hyaluronate, Madecassic Acid, Asiaticoside, Asiatic Acid, Squalane, Caprylic/Capric Triglyceride, Hydrogenated Lecithin, Glyceryl Stearate, Cholesterol, Propanediol, Disodium EDTA, Glyceryl Acrylate/Acrylic Acid Copolymer, Cellulose Gum, Xanthan Gum, Inulin, Cellulose, Glucose, Fructose, Polyglucuronic Acid, Hydroxyethyl Urea, Ethylhexylglycerin, Hydroxyacetophenone, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Glycerin, Dipotassium Glycyrrhizate, 1,2-Hexanediol, Carbomer, Arginine
